相关实验视频

Updated: Jan 13, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

可以解释的SHAP-XGBoost与DAT和临床数据用于在帕金森病中结步态检测

Shuxian Jin¹, Yumeng Qi², Yayun Yan¹

¹Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.

NPJ Parkinson's disease

|January 7, 2026

概括

一个可解释的模型使用临床数据和多巴胺转运器成像准确地识别了帕金森病中的L-多巴响应步态结 (FOG). 这种方法有助于早期检测和干预这种令人虚弱的FOG症状.

科学领域:

神经学神经学
医疗成像医学成像
机器学习机器学习

背景情况:

步态结 (FOG) 是帕金森病 (PD) 的重要症状之一,影响了运动能力.
早期发现L-多巴反应性FOG对于有效的患者管理至关重要.

研究的目的:

开发和验证一个可解释的AI模型,用于识别L-多巴响应FOG.
将临床评估与多巴胺载体 (DAT) 成像进行整合,以改善FOG预测.

主要方法:

使用516名参与者的临床数据和DAT成像,开发了SHAP-XGBoost模型.
该模型在内部队列上进行了训练,并在内部和外部 (PPMI) 测试集上进行了验证.
使用SHAP分析来确定FOG预测的特征重要性.

主要成果:

该模型实现了高预测性能,AUC为0.90 (内部训练),0.89 (内部测试) 和0.75 (外部PPMI测试).
霍恩和雅尔的分期和DAT在逆侧前门中的可用性是关键预测因素.
确定了疾病持续时间,年龄和MDS-UPDRS第三部分得分的具体值.

结论:

可解释的SHAP-XGBoost模型有效地检测出L-多巴反应的FOG.
反侧前门的DAT可用性是FOG病理生理学的关键因素.
该模型为帕金森病的早期FOG检测提供了有价值的工具.

更多相关视频

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...